新型缝合装置用于内镜黏膜下剥离术后大缺损闭合的安全性和有效性(附视频)
这项前瞻性单中心可行性研究纳入33例患者,评估OverStitch Sx单通道内镜缝合系统闭合内镜黏膜下剥离术后大缺损的安全性和可行性。技术成功率为93.9%,临床成功率为90.9%,当日出院率为77.4%,总不良事件率为35.7%,未报告穿孔。结论认为该装置能安全有效地闭合大缺损,未来需试验确定其相较于OverStitch在困难部位闭合缺损的优越性。
要点
- OverStitch Sx闭合ESD术后大缺损的技术成功率为93.9%,临床成功率为90.9%。
- 总不良事件率为35.7%,包括迟发性出血、直肠疼痛、直肠狭窄和暂时性吞咽困难,无穿孔。
- 当日出院率为77.4%,病变平均直径为5.38 ± 2.52 cm。
核心结论
- OverStitch Sx能够安全有效地闭合ESD术后大缺损。
- 未来需开展试验以确定其相较于OverStitch在困难部位闭合缺损的优越性。
研究设计与样本
- 前瞻性单中心可行性研究,纳入33例接受OverStitch Sx系统闭合ESD术后大缺损的患者。
主要发现
- 纳入病变的平均直径为5.38 ± 2.52 cm。
- 70%的病例缺损占据管腔周径≥50%。
- 整块切除、R0切除和治愈性切除分别达到97%、87.5%和78.8%。
- 技术成功和临床成功分别为93.9%和90.9%。
- 当日出院率为77.4%,总不良事件率为35.7%,包括1例直肠ESD后迟发性出血经保守处理、7例自愈性直肠疼痛、1例需扩张的直肠狭窄和1例暂时性吞咽困难,未报告即刻或迟发性穿孔。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Endoscopic suturing enables full closure of large defects after endoscopic submucosal dissection (ESD). However, its use is limited by the need for a double-channel endoscope. A novel closure system, the OverStitch Sx (Apollo Endosurgery, Austin, Tex, USA), compatible with any single-channel endoscope, was introduced to address these shortcomings. The aim of this study was to assess the safety and feasibility of OverStitch Sx for the closure of large defects after ESD. METHODS: This is a prospective single-center feasibility study of patients who underwent closure of large defects after ESD using the OverStitch Sx system. Main outcomes of the study are technical and clinical success, same-day discharge rate, and adverse event rate. RESULTS: Thirty-three patients were enrolled. The mean diameter of included lesions was 5.38 ± 2.52 cm. The defect occupied ≥50% of the lumen circumference in 70% of the cases. En-bloc resection, R0 resection, and curative resection were achieved in 97%, 87.5%, and 78.8% of patients, respectively. Technical success and clinical success were seen in 93.9% and 90.9% of the cases, respectively. Same-day hospital discharge was achieved in 77.4% of patients. Total adverse event rate was 35.7%, including delayed bleeding in 1 patient after rectal ESD that was managed conservatively, self-resolving rectal pain in 7 patients, rectal stricture requiring dilation in 1 patient, and temporary dysphagia in 1 patient. No immediate or delayed perforation was reported. CONCLUSIONS: OverStitch Sx enabled safe and effective closure of large defects after ESD. Future trials are needed to determine its superiority over OverStitch for the closure of defects in challenging locations. (Clinical trial registration number: NCT04361227.).
引用
- Keihanian T, Zabad N, Khalaf M, et al. Safety and efficacy of a novel suturing device for closure of large defects after endoscopic submucosal dissection (with video). Gastrointest Endosc. 2023. PMID: 37061137. doi:10.1016/j.gie.2023.04.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。